Navigate to Other Sector


Healthcare Newsletter – November 2018

Sandoz drops Rituxan biosimilar in US after request for more data -Reminder of continuing commercial challenges
Microsoft makes FHIR easier to access for developers
Non – traditional partnership pursuing early diagnostic for Alzheimer’s disease
Encouraging Development for Strengthening Overall Healthcare Delivery Ecosystem in India
Blurring Lines between Devices & Diagnostics in the Field of Oncology
Outbound M&A by Indian Pharma Giants Fueled By Specialty Pharma Focus

Discussion — No responses

Show Buttons
Hide Buttons